CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-15 | Doerfler Douglas President and CEO | Sale | −123,263 | $12.16 | $1.5M | 333,197 |
| 2021-11-15 | Doerfler Douglas President and CEO | Exercise or conversion · Employee Stock Option (right to buy) | −123,263 | 519,970 | ||
| 2021-11-12 | Masoud Maher EVP and General Counsel | Exercise or conversion | +25,722 | $2.08 | $54K | 25,722 |
| 2021-11-12 | Masoud Maher EVP and General Counsel | Sale | −25,722 | $12.66 | $326K | 0 |
| 2021-11-12 | Masoud Maher EVP and General Counsel | Exercise or conversion · Employee Stock Option (right to buy) | −25,722 | 99,278 | ||
| 2021-11-12 | Murphy Amanda Louise Chief Financial Officer | Exercise or conversion | +51,103 | $4.42 | $226K | 51,103 |
| 2021-11-12 | Murphy Amanda Louise Chief Financial Officer | Sale | −51,103 | $12.66 | $647K | 0 |
| 2021-11-12 | Murphy Amanda Louise Chief Financial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −51,103 | 1,098,897 | ||
| 2021-11-12 | Ross Thomas M. EVP, Global Sales | Exercise or conversion | +42,590 | $0.84 | $36K | 42,590 |
| 2021-11-12 | Ross Thomas M. EVP, Global Sales | Sale | −42,590 | $12.66 | $539K | 0 |
| 2021-11-12 | Ross Thomas M. EVP, Global Sales | Exercise or conversion · Employee Stock Option (right to buy) | −42,590 | 139,515 | ||
| 2021-11-12 | Holtz Ron SVP and CAO | Exercise or conversion | +21,485 | $0.04 | $859 | 171,736 |
| 2021-11-12 | Holtz Ron SVP and CAO | Sale | −46,485 | $12.65 | $588K | 125,251 |
| 2021-11-12 | Holtz Ron SVP and CAO | Exercise or conversion · Employee Stock Option (right to buy) | −21,485 | 233,807 | ||
| 2021-11-12 | Doerfler Douglas President and CEO | Exercise or conversion | +1,847 | $0.04 | $74 | 435,044 |
| 2021-11-12 | Doerfler Douglas President and CEO | Sale | −101,847 | $12.66 | $1.3M | 333,197 |
| 2021-11-12 | Doerfler Douglas President and CEO | Exercise or conversion · Employee Stock Option (right to buy) | −1,847 | 643,233 | ||
| 2021-08-09 | THOMPSON J STARK PHD Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-08-09 | Ross Thomas M. EVP, Global Sales | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-08-09 | Murphy Amanda Louise Chief Financial Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 20 of 21 · 411 trades